Recent Updates
Recently added Catalysts

Upcoming Catalyst

Drug Pipeline Intelligence

Clinical Trial Results

Inside Trades

Options Data

News Section

Hedge Funds

Ownership Trends

Competitive Position

Tilray Brands, Inc. Common Stock

$4.03

+0.09 (+2.2%)

Market Cap
765.72 M
EPS
-13.66
P/E Ratio
-0.48 $
Value Trade
19.10 M
SEC Financials
Q1 2026
  • Dilution Risk

    25%
  • Revenue

    206.73 M

  • R&D Expenses

    62.00 K


  • Total Assets

    2.07 B

  • Total Liabilities

    549.12 M

  • Equity

    1.56 B

  • D/E Ratio

    12,345

%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Stable
  • Cash Position

    219.93 M

  • Monthly Burn

    8.79 M

  • Runway

    21.1 mo

  • Burn Trend

    Accelerating
  • SEC Filing

    Apr 1, 2026
Overview
Volume
5.13 M
52 Week Range
3.51 - 23.20
% held by Insiders
0.73 %
% held by Institutions
9.2 %
Enterprise Value
786.22 M
Total Shares
119.54 M
Short %
13.62 %
Float Shares
118.59 M
Company Description
HQ: 655 MADISON AVENUE, NEW YORK, ...
Employees:2,842

locked

Upcoming Catalyst
Catalyst Drug/Treatment Stage Probability of Approval Description Drug Type Therapeutic Area Source
Example Drug Treatment for example condition requiring FDA review
Phase 3
-%

FDA review of the new drug application for the treatment of example condition.

Read More
Small Molecule
Oncology
Example Drug Treatment for example condition requiring FDA review
Phase 3
-%

FDA review of the new drug application for the treatment of example condition.

Read More
Small Molecule
Oncology
Example Drug Treatment for example condition requiring FDA review
Phase 3
-%

FDA review of the new drug application for the treatment of example condition.

Read More
Small Molecule
Oncology
Unlock Upcoming Catalyst data

Catalyst Timeline

Dated clinical, regulatory & corporate events for Tilray Brands, Inc. Common Stock

3Total events
0Upcoming
1Tier-1 (high impact)
2026 – 2026Coverage

Event history 2

TBD
Quarterly UpdateCorporate
Subscribe to view catalyst details
TBD
Product LaunchZONNAPost-Market
Subscribe to view catalyst details
Unlock the full Catalyst Timeline
Past FDA Catalysts & PDUFA Decisions
Date Drug Catalyst Stage Outcome Reaction Event Move % Best Trade %
Example Drug
Phase 3 data readout
Phase 3
0%
0%
Example Drug
Phase 3 data readout
Phase 3
0%
0%
Example Drug
Phase 3 data readout
Phase 3
0%
0%
Unlock Historical Catalyst data
Drug Pipeline Intelligence
Unlock Drug Pipeline Intelligence
Clinical Trial Results
Drug Name Indications Phase Date Trial Results Summary Title Source
Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01

The study met its primary endpoint demonstrating statistically significant improvement.

Read More

Phase 3 Study Results Announcement

Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01

The study met its primary endpoint demonstrating statistically significant improvement.

Read More

Phase 3 Study Results Announcement

Example Drug
Example indication for clinical evaluation
Phase 3
2025-12-01

The study met its primary endpoint demonstrating statistically significant improvement.

Read More

Phase 3 Study Results Announcement

Unlock Clinical Trial Results data
Inside Trades
TREND
CORPORATE INSIDERS BOUGHT SHARES WORTH 1.8M IN THE LAST 3 MONTHS
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLD
INSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Unlock Inside Trades data
Hedge Funds
TREND
HEDGE FUNDS INCREASED HOLDINGS BY 200.0K SHARES IN THE LAST QUARTER
Shares Held
2040.00B1530.00B1020.00B510.00B0
Q3
2024
Q4
2024
Q1
2025
Q2
2025
HEDGE FUNDS
SOLD
HEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Fund Count
60%
Share Volume
25%
Conviction
15%
HedgeFund Name
( 3 )
% of Portfolio Current MV
-
Shares Owned
-
Activity
Avg Price $0

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K

Example Capital Management

2.5 %
15.00 M
250.00 K
Unlock Hedge Funds table data
TLRY Institutional Ownership Trends
Current Insider %
5.20%
+0.00%
Current Institutional %
62.40%
+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
ExpirationVolumeOpen InterestImplied Volatility CallsImplied Volatility Puts
CallsPutsPut-Call RatioCallsPutsPut-Call RatioIVOiWaIvVWaIvIVOiWaIvVWaIv
2026-09-180 0.00 0 0 - - - - - -
2026-09-180 0.00 0 0 - - - - - -
2026-09-180 0.00 0 0 - - - - - -
Unlock Option Chain Statistics data
Option Chain
CallsStrikePuts
Last PriceVolumeOpen InterestLast PriceVolumeOpen Interest
No data available
Unlock Option Chain data
Unlock Options Chart data
Open interest
0 600K 1.2M 1.8M Avg OI 1.00 M Open Interest
0 1 2 3 1.1 Put-Call Ratio
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
0 450K 900K 1.4M Avg OV 750.00 K Option Volume
0 1 2 3 0.95 Put-Call Ratio
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-TLRY
Jul 28, 2026
TLRYGeneral
▲ +2.2%today

Tilray Brands Delivers Record Fiscal 2026 Revenue and Adjusted EBITDA; Demonstrating the Strength of its Diversified Global Platform Across Cannabis, Beverage, Hospitality and Wellness

Tilray Brands reported record fiscal 2026 revenue of $915 million, reflecting a strong growth strategy across its diversified platform in cannabis, beverage, hospitality, and wellness. The company achieved a 34% increase in international medical cannabis revenue and improved its adjusted EBITDA to $61.1 million. Despite a net loss of $105.2 million, Tilray remains optimistic about future growth, projecting over $1 billion in annual revenue for fiscal 2027.

Read more →
-TLRY
Jul 23, 2026
TLRYGeneral

Tilray Brands Launches ZONNA, Introducing New THC Pouches for Cannabis Consumers

Tilray Brands has launched ZONNA, a new cannabis brand featuring fast-acting THC pouches. Designed for discreet and smoke-free consumption, these pouches utilize innovative Capsoil™ technology. Each pouch contains 10 mg of THC, ensuring a controlled dose. The product is now available through licensed retailers across Canada.

Read more →
-TLRY
Jul 17, 2026
TLRYGeneral

BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland

BrewDog and Tilray Brands have launched a £1 million bar tab for football fans in England, Scotland, and Ireland, starting July 20, 2026. This initiative aims to enhance the football experience by encouraging fans to gather at participating BrewDog pubs. Fans can redeem two free pints per person through BrewDog's Treats loyalty platform until September 30, 2026.

Read more →
-TLRY
Jul 13, 2026
TLRYConferences/Events

Tilray Brands to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on July 28, 2026

Tilray Brands, Inc. will release its financial results for Q4 and fiscal year 2026 on July 28, 2026. The announcement will be followed by a live conference call at 4:30 PM ET, which will be accessible via a webcast. The company continues to position itself as a leader in the cannabis and wellness sectors.

Read more →
-TLRY
Jun 29, 2026
TLRYGeneral

Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition

Tilray Brands has announced the acquisition of HelloMD Corporation, a digital healthcare platform, to enhance its medical cannabis offerings in Canada. This acquisition aims to improve direct-to-patient capabilities and create a fully integrated framework for medical cannabis. It will also support patient education and engagement, positioning Tilray for growth in the global medical cannabis market.

Read more →
-TLRY
Jun 11, 2026
TLRYGeneral

BrewDog Rolls Back Pint Prices to £2 Across Scotland for 72-Hour Bank Holiday Weekend, Celebrating the National Team’s Return

BrewDog is reducing pint prices to £2 across its Scottish locations for a 72-hour bank holiday weekend to celebrate the Scottish national team's return to international competition. The promotion, available from June 14 to June 16, includes a special online bundle for fans. This initiative is part of BrewDog's broader summer football campaign.

Read more →
-TLRY
Jun 3, 2026
TLRYGeneral
▼ -5%on this news

SweetWater Brewing Unveils Atlanta-Wide Soccer Celebration as Global Fans Descend on the City This Summer

SweetWater Brewing Company has announced a citywide soccer celebration in Atlanta for summer 2026, coinciding with a major international sporting event. The initiative includes various fan experiences, watch parties, and collaborations with local breweries. As the Official Craft Beer Partner of Atlanta United, SweetWater aims to connect local fans with visitors through engaging activities and special promotions.

Read more →
-TLRY
May 28, 2026
TLRYGeneral

Premium Craft Cannabis Brand Broken Coast Launches Cherry Ztripez Flower and Pre-Rolls for Summer

Tilray Brands, Inc. has launched Cherry Ztripez, a new premium craft cannabis strain under its Broken Coast brand. This indica-dominant strain is cultivated with a focus on quality and consistency, reflecting the brand's commitment to premium craft cannabis. Cherry Ztripez will be available in various formats, including whole flower and pre-rolls, enhancing the brand's summer offerings.

Read more →
-TLRY
May 27, 2026
TLRYGeneral

BrewDog Turns This Summer’s Global Football Tournament into a Nationwide Celebration of Beer, Bars and Big Match Moments

BrewDog is launching a major summer campaign called 'Underdog' to celebrate international football. The initiative includes a nationwide promotion offering a chance to win free beer for a year, alongside various match-day events at BrewDog bars. The campaign aims to enhance consumer engagement through interactive experiences and themed promotions, positioning BrewDog as a leading choice for fans this summer.

Read more →
-TLRY
May 26, 2026
TLRYConferences/Events

Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026

Tilray Medical announced its participation in Cannabis Europa London 2026, a key forum for discussing medical cannabis policy and regulation in Europe. José Tempero, Director of International Medical Affairs, will speak on a panel about evidence-based policy design. The event aims to foster collaboration among stakeholders to enhance patient access and responsible cannabis use.

Read more →
-TLRY
May 4, 2026
TLRYGeneral

10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails

10 Barrel Brewing, a subsidiary of Tilray Brands, has launched two new ready-to-drink cocktails: Clean Slate and Salty Sips. Clean Slate is a non-alcoholic functional beverage designed for recovery, while Salty Sips is a low-sugar vodka cocktail. Both products aim to meet the evolving preferences of consumers and will initially be available in the Pacific Northwest.

Read more →
-TLRY
Apr 30, 2026
TLRYGeneral

SweetWater Brewing Company and Salt Life Launch Livin’ Salty: The Ultimate Summer Craft Brew Collaboration

SweetWater Brewing Company has launched Livin’ Salty, a salt and lime lager, in collaboration with Salt Life. This refreshing beer, with a 5% ABV, is designed for summer enjoyment, featuring real limes and salt. It will be available in various packaging options and at multiple locations, including the SweetWater taproom and Salt Life Food Shacks.

Read more →
-TLRY
Apr 23, 2026
TLRYGeneral
▼ -11.8%on this news

BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer

BrewDog USA, backed by Tilray Brands, has announced an innovative lineup of products for spring and summer, focusing on bold flavors and new beverage categories. The introduction of Juice Club, a non-alcoholic range, alongside the popular Elvis Juice and Hazy Jane, signals BrewDog's commitment to meet modern consumer preferences. Additionally, the company aims to enhance community impact by donating a portion of sales from BrewDog IPA.

Read more →
-TLRY
Apr 20, 2026
TLRYGeneral

Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care

Tilray Brands, Inc. celebrates 4/20 by emphasizing its leadership in medical cannabis and commitment to patient care. CEO Irwin D. Simon highlighted the company's evolution and its extensive portfolio of pharmaceutical-grade products. With operations across multiple continents, Tilray aims to enhance access to medical cannabis and support over 400,000 patients globally.

Read more →
-TLRY
Apr 15, 2026
TLRYGeneral

Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership Tilray Advances UK Healthcare Platform with Lyphe Acquisition, Positions BrewDog for Strong Growth, and Prepares for U.S. Rescheduling and Medic

Tilray Brands, Inc. has announced a series of strategic initiatives aimed at enhancing its position in the global healthcare, cannabis, and beverage markets. The acquisition of the Lyphe Group strengthens its medical cannabis platform in the UK, allowing for a more integrated patient care approach. In addition, Tilray is focusing on revitalizing the BrewDog brand to position it for future growth while actively preparing for the potential U.S. medical cannabis market rescheduling. The company is also launching an $180 million ATM program to support its beverage expansion plans.

Read more →
-TLRY
Mar 26, 2026
TLRYGeneral
▼ -5.8%on this news

Tilray Brands Announces Partnership with Popsicle® to Launch Popsicle Adult Beverages

Tilray Brands has partnered with The Magnum Ice Cream Company to launch a new line of Popsicle flavored hard beverages for adults. The drinks, featuring iconic flavors like Hard Cherry, Hard Orange, and Hard Grape, will have a 5% ABV and will be available in select retailers starting March 2026. A special Popsicle Hard Firecracker beverage is also set to launch in May 2026, expanding the product line further.

Read more →
-TLRY
Mar 25, 2026
TLRYConferences/Events

Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026

Tilray Brands, Inc. has announced that it will release its financial results for the third fiscal quarter ending February 28, 2026, on April 1, 2026. A live conference call will be held at 8:30 AM Eastern Time to discuss these results. This event highlights Tilray's commitment to transparency and investor relations.

Read more →
-TLRY
Mar 2, 2026
TLRYGeneral

Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating a ~$500 Million Global Craft Beer and Beverage Platform

Tilray Brands has acquired BrewDog's global brand and UK brewing operations for £33 million, aiming to create a ~$500 million craft beverage platform. The acquisition is expected to generate ~$200 million in annual net revenue and ~$6 - $8 million in adjusted EBITDA by fiscal 2027. This strategic move enhances Tilray's market presence and operational capacity in the beverage sector.

Read more →
-TLRY
Feb 26, 2026
TLRYGeneral

Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spring Lineup Across Canada

Tilray Brands, Inc. has announced the launch of Good Supply's new spring product lineup, featuring high-potency vapes, flower, and pre-rolls. The offerings aim to meet the growing consumer demand for high-THC products while enhancing brand loyalty and retail performance. The lineup includes innovative flavors and limited-edition strains designed to attract consumers in the competitive cannabis market.

Read more →
-TLRY
Feb 18, 2026
TLRYGeneral

Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership

Tilray Brands has entered into an exclusive multi-year licensing agreement with the Carlsberg Group, allowing Tilray to produce and distribute Carlsberg's beer brands in the U.S. starting January 1, 2027. This partnership aims to enhance Carlsberg's market share in the premium beer segment and leverage Tilray's brewing capabilities. The agreement includes an initial five-year term with potential for renewal based on performance.

Read more →
-TLRY
Feb 12, 2026
TLRYGeneral

Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals

Tilray Pharma has formed a strategic agreement with Smartway Pharmaceuticals to enhance the availability of pharmaceutical products in the UK. This collaboration aims to leverage Smartway's distribution network and CC Pharma's procurement capabilities, facilitating better access to medicinal products. The agreement is part of Tilray's broader strategy to expand its presence in the European medical landscape.

Read more →
-TLRY
Feb 4, 2026
TLRYGeneral

Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois

Breckenridge Distillery has appointed Romano Beverage to manage its distribution in Illinois. This partnership aims to enhance the reach of Breckenridge's full spirits collection, including their award-winning bourbon and newly launched Mountain Shot. The collaboration is expected to accelerate growth and solidify the brand's presence in the state.

Read more →
-TLRY
Feb 4, 2026
TLRYGeneral

Tilray’s CC Pharma Recognized as a TOP 100 Innovator in Germany

Tilray's CC Pharma has been honored as a TOP 100 Innovator in Germany, showcasing its innovative strength and commitment to operational excellence. This recognition reflects the company's role in enhancing patient access to a wide range of pharmaceuticals, including medical cannabis. The award validates CC Pharma's disciplined innovation strategy and its position as a trusted partner in the healthcare supply chain.

Read more →
-TLRY
Feb 3, 2026
TLRYGeneral

Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events, Big Game Day Deals, and Fan Experiences Announced

Tilray Brands is preparing for Super Bowl Sunday with special events at its craft beer tap rooms across the U.S. The tap rooms will offer exclusive game day promotions, including food and drink specials, live entertainment, and giveaways. Participating breweries include SweetWater, Montauk, and Breckenridge, among others, inviting fans to celebrate the big game.

Read more →
-TLRY
Jan 29, 2026
TLRYGeneral

Terrapin Beer Co. Turns Up the Volume with a New Brand Identity Rooted in Music, Art and Craft Beer Culture

Terrapin Beer Co., a subsidiary of Tilray Brands, has unveiled a comprehensive brand refresh that includes new packaging, logos, and artist collaborations. The updated identity aims to resonate with a new generation of beer enthusiasts while maintaining the brand's roots in music and craft beer culture. The refreshed designs will be rolled out across various consumer channels starting this month.

Read more →
-TLRY
Jan 27, 2026
TLRYGeneral

SweetWater 420 Fest Unveils Powerhouse 2026 Lineup: Umphrey’s McGee, Thievery Corporation & Chromeo to Headline

SweetWater Brewing Company has announced the lineup for the 2026 SweetWater 420 Fest, scheduled for April 17-18. Headliners include Umphrey's McGee and Thievery Corporation, with a diverse range of supporting acts. The festival will take place at Atlanta's new Shirley Clarke Franklin Park, emphasizing affordability with reduced ticket prices. The event aims to celebrate music and community in an outdoor setting.

Read more →
-TLRY
Jan 22, 2026
TLRYGeneral
▲ +5.3%on this newsshared move

Tilray Medical renforce sa présence sur le marché italien avec le lancement de Tilray Medical Italia et l’élargissement de son portefeuille de produits à base de cannabis thérapeutique

Tilray Medical has launched Tilray Medical Italia, enhancing its presence in the Italian therapeutic cannabis market. This strategic move aims to unify its operations under a single brand while expanding its portfolio of approved cannabis products. The partnership with Molteni Farmaceutici will support medical professionals and ensure high-quality product delivery to patients across Italy.

Read more →
-TLRY
Jan 22, 2026
TLRYGeneral
▲ +5.3%on this newsshared move

Tilray Medical stärkt die Marktpräsenz in Italien mit der Gründung von Tilray Medical Italia und einem erweiterten Portfolio an medizinischen Cannabis-Produkten

Tilray Medical has announced the establishment of Tilray Medical Italia, enhancing its presence in Italy's medical cannabis market. This initiative includes a growing portfolio of products approved by the Italian health authorities and a partnership with Molteni Farmaceutici. The move aims to strengthen Tilray's commitment to providing high-quality medical cannabis solutions across Europe.

Read more →
-TLRY
Jan 22, 2026
TLRYGeneral
▲ +5.3%on this newsshared move

Tilray Medical rafforza la propria presenza sul mercato italiano con il lancio di Tilray Medical Italia e l'ampliamento del proprio portafoglio di prodotti a base di cannabis terapeutica

Tilray Medical has announced the launch of Tilray Medical Italia, enhancing its presence in the Italian therapeutic cannabis market. This strategic move includes a growing portfolio of cannabis products authorized by the Italian Ministry of Health. The partnership with Molteni Farmaceutici aims to support medical training and ensure compliance with regulatory standards. This initiative aligns with Tilray's broader European strategy to unify its operations under a single global medical brand.

Read more →
-TLRY
Jan 22, 2026
TLRYGeneral
▲ +5.3%on this newsshared move

SweetWater Introduces Big Trip Double IPA: A Bold New Craft Beer

SweetWater Brewing Company has launched Big Trip Double IPA, a high-ABV extension of its popular Daytrip IPA. This new craft beer features a bold 9% ABV and a blend of hops that deliver bright citrus notes and a smooth aroma. The product will be available nationwide in various formats, catering to the growing trend of Double IPAs in the Southeast.

Read more →
-TLRY
Jan 22, 2026
TLRYGeneral
▲ +5.3%on this newsshared move

Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio

Tilray Medical has launched Tilray Medical Italia, enhancing its presence in Italy's medical cannabis market. This move reflects the company's commitment to a unified platform across Europe. The new entity will offer a range of authorized medical cannabis products, supported by a partnership with Molteni Farmaceutici, ensuring compliance and quality in distribution.

Read more →
-TLRY
Jan 5, 2026
TLRYGeneral

Enhance Your Dry January with Mindful Sipping: Try Tilray’s Mollo and XMG Cannabis Beverages

Tilray Brands, Inc. is promoting its cannabis-infused beverages, Mollo and XMG, as part of a campaign for Dry January. The initiative encourages Canadians to choose flavorful, alcohol-free options while socializing or relaxing. With the non-alcoholic beverage market expanding, Tilray aims to provide consumers with innovative alternatives that maintain bold tastes and consistent cannabinoid profiles.

Read more →
-TLRY
Dec 22, 2025
TLRYConferences/Events
▼ -6.6%on this news

Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026

Tilray Brands, Inc. will release its financial results for the second quarter of fiscal year 2026 on January 8, 2026. The announcement follows the end of the fiscal quarter on November 30, 2025. A live conference call will be held at 4:30 PM ET on the same day, allowing investors to engage with the company. Questions can be submitted via Robinhood and Say Technologies until January 7, 2026.

Read more →
-TLRY
Dec 11, 2025
TLRYGeneral

Redecan Cannabis Brand Elevates the Diamond Vape Category with the Launch of Amped Live Resin Liquid Diamond Vapes

Tilray Brands has launched the Amped Live Resin Liquid Diamond vape cartridges under its Redecan brand. This product combines Legit Live Resin with Liquid Diamonds to enhance flavor and aroma. The cartridges are designed for a smooth draw and are set to be available nationally in early 2026. The launch aligns with a growing trend in the Canadian cannabis market.

Read more →
-TLRY
Nov 24, 2025
TLRYGeneral
▲ +6.5%on this news

Tilray Unveils Good Supply Vapes in Québec Following the Recent Introduction of Vape Products in Québec

Tilray Brands has launched Good Supply vape products in Québec, marking a significant milestone in the province's legal cannabis market. The new offerings include popular 1 g 510-thread cartridges in Pineapple Express and Blue Dream strains. These products are designed for compatibility with standard 510 batteries and are available for purchase both online and in-store.

Read more →
-TLRY
Nov 24, 2025
TLRYGeneral
▲ +6.5%on this news

Tilray dévoile les produits de vapotage Good Supply au Québec avec l’introduction récente des produits de vapotage au Québec

Tilray Brands, Inc. has launched Good Supply vaping products in Quebec, coinciding with the introduction of legal cannabis vaping products in the province. The products include 1g cartridges of popular strains such as Pineapple Express and Blue Dream, which are compatible with standard 510 batteries. This launch is seen as a significant moment for consumers and the cannabis industry in Quebec.

Read more →
-TLRY
Nov 6, 2024
TLRYGeneral
▼ -13%on this news

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE NABIL SALAMA, individually and on behalf of all others similarly situated, Plaintiff, v. IRWIN D. SIMON, JODI BUTTS, DAVID CLANACHAN, JOHN M. HERHALT, DAVID HOPKINSON, TH

A class action lawsuit has been filed against Tilray Brands, Inc. and its board members by plaintiff Nabil Salama, alleging false disclosures in proxy statements regarding share authorization votes. The lawsuit claims the board misinformed stockholders about voting standards required for increasing the number of authorized shares. This legal action seeks to compel the board to correct these disclosures, particularly following a pattern of misleading information in previous proxy statements. The case highlights ongoing governance issues and potential risks to stockholder interests associated with Tilray's capital structure.

Read more →
-TLRY
May 17, 2024
TLRYGeneral
▼ -6.6%on this news

TILRAY BRANDS ANNOUNCES AT-THE-MARKET

Tilray Brands, Inc. has announced a $250 million at-the-market equity program to facilitate strategic acquisitions and investments, particularly as U.S. cannabis regulations evolve. The company has partnered with TD Securities and Jefferies to execute this offering. The net proceeds from the program are intended for growth-oriented ventures rather than general working capital. Tilray's move indicates a strong commitment to expanding within the transformative cannabis market.

Read more →
-TLRY
Jun 22, 2023
TLRYGeneral

TILRAY BRANDS COMPLETES ACCRETIVE ACQUISITION OF HEXO CORP. LEADING THE NEXT EVOLUTION OF CANADIAN CANNABIS Creates Canada's Largest Cannabis Company by Revenue and Increases Tilray's #1 Leading Cannabis Share by 44% wit

Tilray Brands has completed its acquisition of HEXO Corp, solidifying its status as the largest cannabis company in Canada by revenue. This strategic move enhances Tilray's market share across various cannabis product categories, including becoming the leading company in flower, oils, and concentrates. The combined strengths of both companies are expected to generate over $27 million in operational and cost synergies, positioning Tilray for significant future growth in the Canadian cannabis market. Tilray also aims to leverage HEXO's production capabilities to enhance its consumer base and operational efficiency.

Read more →
-TLRY
Jul 28, 2022
TLRYGeneral
▲ +12%on this news

PRESS RELEASE

Tilray Brands, Inc. Reports Record Fiscal Year 2022 Results FY2022 Net Revenue Grew 22% to $628 Million Compared to the Prior Year; On a Constant Currency Basis, Net Revenue Increased by 29% Fourth Quarter Net Revenue Grew 8% to $153 Million Compared to the Prior Year Period; O

Read more →
-TLRY
Jul 12, 2022
TLRYGeneral

Tilray Brands Announces Closing of Transaction with HEXO, Laying Groundwork for the Next Evolution of Canadian Cannabis Alliance Looks to Enhance Consumer Experience and Strengthen Tilray Brands' Potential for U.S. Feder

Tilray Brands Announces Closing of Transaction with HEXO, Laying Groundwork for the Next Evolution of Canadian Cannabis Alliance Looks to Enhance Consumer Experience and Strengthen Tilray Brands' Potential for U.S. Federal Legalization and International Expansion Transaction E

Read more →
-TLRY
Jun 14, 2022
TLRYGeneral

Tilray Brands Announces Enhancements to Accretive Strategic Transaction with HEXO Amended Terms Include Increased Discount on Purchase Price of HEXO Note and Reduced Tilray Conversion Price on HEXO Shares Reaffirms $80 M

Tilray Brands Announces Enhancements to Accretive Strategic Transaction with HEXO Amended Terms Include Increased Discount on Purchase Price of HEXO Note and Reduced Tilray Conversion Price on HEXO Shares Reaffirms $80 Million in Projected Shared Cost-Saving Synergies Expected

Read more →
-TLRY
Apr 12, 2022
TLRYGeneral

TILRAY BRANDS ANNOUNCES DEFINITIVE AGREEMENT WITH HEXO CORP. RELATED TO HEXO'S SENIOR SECURED CONVERTIBLE NOTE - Canada's Top Two Cannabis Market Leaders to Join Forces, Strengthening Operations and Unlocking up to US$80

TILRAY BRANDS ANNOUNCES DEFINITIVE AGREEMENT WITH HEXO CORP. RELATED TO HEXO'S SENIOR SECURED CONVERTIBLE NOTE - Canada's Top Two Cannabis Market Leaders to Join Forces, Strengthening Operations and Unlocking up to US$80 Million of Shared Cost - Strategic Alliance Establishes C

Read more →
-TLRY
Apr 6, 2022
TLRYGeneral

APRIL 6, 2022 Tilray Brands, Inc. Reports Third Quarter Fiscal Year 2022 Financial Results Profitable Quarter Includes Net Income of $52.5 Million and Adjusted EBITDA of $10.1 Million; 12 th Consecutive Qua

Exhibit 99.1 PRESS RELEASE APRIL 6, 2022 Tilray Brands, Inc. Reports Third Quarter Fiscal Year 2022 Financial Results LEAMINGTON, ON and NEW YORK - April 6, 2022 - Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle an

Read more →
-TLRY
Mar 3, 2022
TLRYGeneral
▼ -7%on this news

TILRAY BRANDS ANNOUNCES PROPOSED AGREEMENT FOR STRATEGIC ALLIANCE WITH HEXO CORP. TILRAY TO ACQUIRE HEXO CORP.'S SENIOR SECURED CONVERTIBLE NOTES Commercial and financial alliance would bring together Canada's top two ca

TILRAY BRANDS ANNOUNCES PROPOSED AGREEMENT FOR STRATEGIC ALLIANCE WITH HEXO CORP. TILRAY TO ACQUIRE HEXO CORP.'S SENIOR SECURED CONVERTIBLE NOTES Commercial and financial alliance would bring together Canada's top two cannabis market share leaders to strengthen operational eff

Read more →
-TLRY
Sep 10, 2021
TLRYFDA Updates

TILRAY STOCKHOLDERS APPROVE PROPOSAL TO INCREASE AUTHORIZED SHARES AT SPECIAL MEETING Providing Company with Additional Shares to Execute Against Strategic Plan to Accelerate Growth and Drive Value Creation NEW YORK &

TILRAY STOCKHOLDERS APPROVE PROPOSAL TO INCREASE AUTHORIZED SHARES AT SPECIAL MEETING Providing Company with Additional Shares to Execute Against Strategic Plan to Accelerate Growth and Drive Value Creation NEW YORK & LEAMINGTON, Ontario - Sept 10, 2021 -- Tilray, Inc. ("Til

Read more →
-TLRY
Aug 19, 2021
TLRYGeneral

TILRAY ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS TO SEPTEMBER 10, 2021 Votes already cast point to support for both the Authorized Shares Proposal and the Governance Proposals Tilray urges stockholders to

TILRAY ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS TO SEPTEMBER 10, 2021 Votes already cast point to support for both the Authorized Shares Proposal and the Governance Proposals Tilray urges stockholders to vote immediately in support of long-term value creation N

Read more →
-TLRY
Aug 17, 2021
TLRYGeneral

TILRAY ACQUIRES MAJORITY POSITION IN AMENDED MEDMEN CONVERTIBLE NOTES Investment Provides Tilray a Potential Accelerated Path into U.S. Cannabis Market Upon Federal Legalization Amendment and Extension of Convertible Not

TILRAY ACQUIRES MAJORITY POSITION IN AMENDED MEDMEN CONVERTIBLE NOTES Investment Provides Tilray a Potential Accelerated Path into U.S. Cannabis Market Upon Federal Legalization Amendment and Extension of Convertible Notes Enables MedMen to Reshape Balance Sheet and Further Acc

Read more →
-TLRY
Jul 30, 2021
TLRYGeneral
▼ -5.3%on this news

filed with the Original Report (the " Prior Exhibit "). The Prior Exhibit included, among other things, certain information related to then-existing compensatory arrangements between the Company's named executive officer

As previously disclosed in the Current Reports on Form 8-K filed by Tilray, Inc., a Delaware corporation ("Tilray" or the "Company"), with the Securities and Exchange Commission (the "SEC") on December 21, 2020 and February 22, 2021, Tilray entered into an Arrangement Agreement

Read more →
-TLRY
Jul 29, 2021
TLRYGeneral

TILRAY ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS TO AUGUST 19, 2021 Preliminary assessment of votes already cast points to overwhelming support for both the Authorized Shares Proposal and the Governance Pr

TILRAY ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS TO AUGUST 19, 2021 Preliminary assessment of votes already cast points to overwhelming support for both the Authorized Shares Proposal and the Governance Tilray urges stockholders to vote immediately in support of

Read more →
-TLRY
May 5, 2021
TLRYGeneral

TILRAY & APHRIA ANNOUNCE CLOSING OF TRANSACTION THAT CREATES THE "NEW" TILRAY - A GLOBAL CANNABIS LEADER Operational Efficiencies Expected to Generate Approximately US$81 Million Annual Pre-Tax Cost-Saving Synergies for

TILRAY & APHRIA ANNOUNCE CLOSING OF TRANSACTION THAT CREATES THE "NEW" TILRAY - A GLOBAL CANNABIS LEADER Operational Efficiencies Expected to Generate Approximately US$81 Million Annual Pre-Tax Cost-Saving Synergies for New Tilray Within Irwin D. Simon, Aphria's Chairman and CE

Read more →
-TLRY
Apr 16, 2021
TLRYFDA Updates

Tilray Board of Directors Announces Approval of Amendment to Company s Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal Requirement NANAIMO, B.C.

Tilray Board of Directors Announces Approval of Amendment to Company s Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal NANAIMO, B.C. April 16, 2021 Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distrib

Read more →
-TLRY
Apr 15, 2021
TLRYGeneral

Special Meeting of Tilray, Inc. Stockholders Adjourned to

of Tilray, Inc. Stockholders Adjourned to April 30, 2021 at 11:00 a.m. Eastern Time NANAIMO, B.C. April 15, 2021 Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the special meeting of Tilray st

Read more →
-TLRY
Mar 26, 2021
TLRYGeneral

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK PATRICIA VIOLINI, Case No.: Plaintiff, v. JURY TRIAL DEMANDED TILRAY, INC., BRENDAN KENNEDY, CHRISTINE ST.CLARE, REBEKAH DOPP, MICHAEL AUERBACH, and SOREN SCHROD

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK PATRICIA VIOLINI, Case No.: Plaintiff, v. JURY TRIAL DEMANDED TILRAY, INC., BRENDAN KENNEDY, CHRISTINE ST.CLARE, REBEKAH DOPP, MICHAEL AUERBACH, and SOREN SCHRODER, COMPLAINT FOR VIOLATIONS OF FEDERAL SECURITIES

Read more →
-TLRY
Feb 25, 2021
TLRYGeneral

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS OF TILRAY UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS OF TILRAY UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On December 15, 2020, Tilray, Inc. ( Tilray ) and Aphria Inc. ( Aphria ), entered into an Arrangement Agreement, under which the businesses of the

Read more →
-TLRY
Dec 16, 2020
TLRYGeneral

APHRIA AND TILRAY COMBINE TO CREATE LARGEST GLOBAL CANNABIS COMPANY WITH PRO FORMA REVENUE OF C$874 MILLION (US$685 MILLION) Complementary, Scalable Medical and Adult-Use Cannabis Businesses Strengthen Leadership Positio

APHRIA AND TILRAY COMBINE TO CREATE LARGEST GLOBAL CANNABIS COMPANY WITH PRO FORMA REVENUE OF C$874 MILLION (US$685 MILLION) Complementary, Scalable Medical and Adult-Use Cannabis Businesses Strengthen Leadership Position in Canada; Expands U.S. and International Reach throug

Read more →
-TLRY
Nov 24, 2020
TLRYGeneral

Form of Exchange Agreement November [ ], 2020 Tilray, Inc. 1100 Maughan Rd. Nanaimo, BC, Canada V9X 1J2 Re: Exchange of 5.00% Convertible Senior Notes due 2023 for Class 2 Common Stock Ladies and Gentlemen: This Exchange

Form of Exchange Agreement Nanaimo, BC, Canada V9X 1J2 Ladies and Gentlemen: This Exchange Agreement and the Terms and Conditions for Exchange of Securities, attached hereto as Exhibit A (the Terms and Conditions and, together with this Exchange Agreement, the Agreement ), is

Read more →
-TLRY
Mar 13, 2020
TLRYGeneral

Tilray, Inc. Announces Pricing of its $90.4 Million Registered Offering MARCH 13, 2020 8:00 AM NANAIMO

Tilray, Inc. Announces Pricing of its $90.4 Million Registered Offering MARCH 13, 2020 8:00 AM NANAIMO, BRITISH COLUMBIA, March 13, 2020 Tilray, Inc. ( Tilray or the Company ) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, anno

Read more →
-TLRY
Dec 13, 2019
TLRYGeneral

Tilray, Inc. Completes Merger With Privateer Holdings, Inc.

Tilray, Inc. Completes Merger With Privateer Holdings, Inc. NANAIMO, British Columbia (BUSINESS WIRE) Dec. 13, 2019 Tilray, Inc. ( Tilray or the Company ) (Nasdaq:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that the me

Read more →
-TLRY
Sep 9, 2019
TLRYGeneral

Tilray, Inc. and Privateer Holdings, Inc. Sign Definitive Agreement to Extend Lock-up and Provide for Orderly Distribution of 75 Million Tilray Shares Held by Privateer

Tilray, Inc. and Privateer Holdings, Inc. Sign Definitive Agreement to Extend Lock-up and Provide for Orderly Distribution of 75 Million Tilray Shares Held by Privateer 77 Percent of Tilray s Total Shares Outstanding to be Released Over Extended Two-Year Lock-up Transaction to

Read more →
-TLRY
Jun 10, 2019
TLRYGeneral

Tilray, Inc. and Privateer Holdings, Inc. Sign Letter of Intent to Extend Lock-up and Provide for Orderly Release of 75 Million Tilray Shares Held by Privateer

Tilray, Inc. and Privateer Holdings, Inc. Sign Letter of Intent to Extend Lock-up and Provide for Orderly Release of 75 Million Tilray Shares Held by Privateer Lock-up to be Extended for up to Two Years on 77 Percent of Tilray's Total Shares Outstanding Transaction Expected to b

Read more →
-TLRY
Jan 15, 2019
TLRYGeneral

Tilray and Authentic Brands Group Sign Global Revenue Sharing Agreement to Develop and Market Consumer Cannabis Brands Agreement leverages Tilray s cannabis expertise and ABG s extensive portfolio of iconic brands that s

Tilray and Authentic Brands Group Sign Global Revenue Sharing Agreement to Develop and Market Consumer Cannabis Brands Agreement leverages Tilray s cannabis expertise and ABG s extensive portfolio of iconic brands that span the entertainment, fashion, streetwear, active, home

Read more →
-TLRY
Dec 19, 2018
TLRYGeneral

Tilray Signs Global Collaboration Agreement with Leading Pharmaceutical Company NANAIMO, B.C. Tilray Canada Ltd., a subsidiary of Tilray Inc. (NASDAQ: TLRY), a global pioneer in the production, research, an

Tilray Signs Global Collaboration Agreement with Leading Pharmaceutical Company NANAIMO, B.C. Tilray Canada Ltd., a subsidiary of Tilray Inc. (NASDAQ: TLRY), a global pioneer in the production, research, and distribution of medical cannabis, announced today that it entered into

Read more →
-TLRY
Oct 4, 2018
TLRYGeneral

Tilray Inc. Upsizes and Prices Offering of US$450 Million Convertible Senior Notes NANAIMO, British Columbia

Tilray Inc. Upsizes and Prices Offering of US$450 Million Convertible Senior Notes NANAIMO, British Columbia October 4, 2018 Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced the pricing of US$450 million

Read more →
-TLRY
Oct 3, 2018
TLRYGeneral

Tilray Inc. Announces Proposed Private Placement of $400 Million of Convertible Senior Notes NANAIMO, British Columbia

Tilray Inc. Announces Proposed Private Placement of $400 Million of Convertible Senior Notes NANAIMO, British Columbia October 3, 2018 Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research, cultivation, production and distribution, today announced that it intends to o

Read more →
Competitive Position
How TLRY ranks across every disease it competes in
Competitive Position is a premium feature
See how TLRY ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial